DEXCOM INC — Director's Dealing 2016

Aug 15, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-08-11

Reporting Person: LORD JONATHAN T MD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-11	Common Stock	S	5000.0	$90.7792	Disposed	131373	Direct
2016-08-12	Common Stock	S	5000.0	$90.5005	Disposed	126373	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $90.76 to $90.78. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2: Included in this number are 4,791 unvested restricted stock units which were granted on May 25, 2016 and shall vest on May 25, 2017.